JP2007519640A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519640A5 JP2007519640A5 JP2006549182A JP2006549182A JP2007519640A5 JP 2007519640 A5 JP2007519640 A5 JP 2007519640A5 JP 2006549182 A JP2006549182 A JP 2006549182A JP 2006549182 A JP2006549182 A JP 2006549182A JP 2007519640 A5 JP2007519640 A5 JP 2007519640A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- halo
- orx
- nrxrx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@@]1[C@@](*N)[C@@]1C Chemical compound C[C@@]1[C@@](*N)[C@@]1C 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400021A SE0400021D0 (sv) | 2004-01-08 | 2004-01-08 | Non-nucleoside reverse transcriptase inhibitors |
| SE0400021-2 | 2004-01-08 | ||
| SE0400585A SE0400585D0 (sv) | 2004-03-09 | 2004-03-09 | NNRTI Antivirals |
| SE0400585-6 | 2004-03-09 | ||
| PCT/SE2004/002034 WO2005066131A1 (en) | 2004-01-08 | 2004-12-30 | Non-nucleotide reverse transcriptase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007519640A JP2007519640A (ja) | 2007-07-19 |
| JP2007519640A5 true JP2007519640A5 (enExample) | 2008-01-24 |
| JP4762917B2 JP4762917B2 (ja) | 2011-08-31 |
Family
ID=34752289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006549182A Expired - Fee Related JP4762917B2 (ja) | 2004-01-08 | 2004-12-30 | 非ヌクレオシド逆転写酵素インヒビター |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7915295B2 (enExample) |
| EP (1) | EP1701942B1 (enExample) |
| JP (1) | JP4762917B2 (enExample) |
| AT (1) | ATE451357T1 (enExample) |
| AU (1) | AU2004312284B2 (enExample) |
| BR (1) | BRPI0418306B8 (enExample) |
| CA (1) | CA2550187C (enExample) |
| DE (1) | DE602004024584D1 (enExample) |
| DK (1) | DK1701942T3 (enExample) |
| EA (1) | EA009700B1 (enExample) |
| ES (1) | ES2337794T3 (enExample) |
| IL (1) | IL176740A (enExample) |
| NZ (1) | NZ548367A (enExample) |
| SG (1) | SG149070A1 (enExample) |
| WO (1) | WO2005066131A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050033663A (ko) * | 2002-09-05 | 2005-04-12 | 메디비르 아베 | 비-뉴클레오시드 역전사효소 억제제 |
| US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| US20060287316A1 (en) * | 2005-04-27 | 2006-12-21 | Ambrilia Biopharma Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
| WO2007062526A1 (en) | 2005-11-30 | 2007-06-07 | Ambrilia Biopharma Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
| GB0608876D0 (en) * | 2006-05-05 | 2006-06-14 | Medivir Ab | Combination therapy |
| AU2007254325B2 (en) * | 2006-05-15 | 2012-05-10 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| ES2628730T3 (es) | 2006-09-21 | 2017-08-03 | Taimed Biologics, Inc. | Inhibidores de proteasa |
| EP3250552B1 (en) * | 2015-01-30 | 2019-03-27 | Genentech, Inc. | Therapeutic compounds and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9906933A (pt) * | 1998-01-16 | 2001-11-27 | Medivir Ab | Antiviróticos |
| WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| SE0100733D0 (sv) | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| SE0102867D0 (sv) * | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| KR20050033663A (ko) * | 2002-09-05 | 2005-04-12 | 메디비르 아베 | 비-뉴클레오시드 역전사효소 억제제 |
-
2004
- 2004-12-30 DE DE602004024584T patent/DE602004024584D1/de not_active Expired - Lifetime
- 2004-12-30 US US10/584,933 patent/US7915295B2/en not_active Expired - Fee Related
- 2004-12-30 JP JP2006549182A patent/JP4762917B2/ja not_active Expired - Fee Related
- 2004-12-30 SG SG200809639-8A patent/SG149070A1/en unknown
- 2004-12-30 AU AU2004312284A patent/AU2004312284B2/en not_active Ceased
- 2004-12-30 BR BRPI0418306A patent/BRPI0418306B8/pt not_active IP Right Cessation
- 2004-12-30 NZ NZ548367A patent/NZ548367A/en not_active IP Right Cessation
- 2004-12-30 WO PCT/SE2004/002034 patent/WO2005066131A1/en not_active Ceased
- 2004-12-30 CA CA2550187A patent/CA2550187C/en not_active Expired - Fee Related
- 2004-12-30 EP EP04809207A patent/EP1701942B1/en not_active Expired - Lifetime
- 2004-12-30 DK DK04809207.6T patent/DK1701942T3/da active
- 2004-12-30 ES ES04809207T patent/ES2337794T3/es not_active Expired - Lifetime
- 2004-12-30 AT AT04809207T patent/ATE451357T1/de not_active IP Right Cessation
- 2004-12-30 EA EA200601289A patent/EA009700B1/ru not_active IP Right Cessation
-
2006
- 2006-07-06 IL IL176740A patent/IL176740A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2552902B1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| JP2021519783A5 (enExample) | ||
| JP2022545359A5 (enExample) | ||
| DK2298747T3 (en) | TRIAZOLD DERIVATIVES OR SALTS THEREOF | |
| CN104884454B (zh) | 用作IL‑12、IL‑23和/或IFNα应答调节剂的酰胺取代的杂环化合物 | |
| CN109790135B (zh) | 用于治疗或预防与痛风或高尿酸血症相关的症状的化合物、组合物和方法 | |
| JP2019529490A5 (enExample) | ||
| US7807684B2 (en) | HIV reverse transcriptase inhibitors | |
| JP2024001048A5 (enExample) | ||
| TW200524935A (en) | Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors | |
| JP2014510774A5 (enExample) | ||
| TW201021798A (en) | Amide acetate derivative having inhibitory activity on endothelial lipase | |
| TW200813010A (en) | Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors | |
| ZA200502384B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| JP2019518050A5 (enExample) | ||
| JPWO2002072145A1 (ja) | Ｅｐ１アンタゴニストを有効成分として含有するうつ病の治療剤 | |
| JP2020533352A5 (enExample) | ||
| JP6261011B2 (ja) | 眼疾患処置薬 | |
| WO1996032384A1 (en) | Novel 4,6-diarylpyrimidine derivatives and salts thereof | |
| JP2024515062A (ja) | 重水素化ｄｈｏｄｈ阻害剤 | |
| JP2025538389A (ja) | グルカゴン様ペプチド１受容体アゴニスト | |
| RU2007108863A (ru) | Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3 | |
| JP2024539655A5 (enExample) | ||
| CN115504995A (zh) | 靶向p53突变体的化合物 | |
| US8933106B2 (en) | 2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereof |